1-6 of 6
Casper Schalkwijk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

Gabriella Gruden, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Silvia Pinach, MSC, Maria Manzo, BSC, Maria Loiacono, BSC, Marinella Tricarico, MD, Giulio Mengozzi, MD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(9):1931–1936
https://doi.org/10.2337/dc12-0089
Published: 14 August 2012
View article titled, NH<sub>2</sub>-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: <subtitle>The role of tumor necrosis factor-α</subtitle>
Open the PDF for NH<sub>2</sub>-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: <subtitle>The role of tumor necrosis factor-α</subtitle> in another window
Includes: Supplementary data
Journal Articles

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Gabriella Gruden, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD
Journal: Diabetes Care
Diabetes Care 2012;35(7):1598–1604
https://doi.org/10.2337/dc11-1531
Published: 12 June 2012
View article titled, Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle>
Open the PDF for Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

Frederik Persson, MD, Peter Rossing, DMSC, Henrik Reinhard, MD, Tina Juhl, Coen D.A. Stehouwer, MD, Casper Schalkwijk, PHD, A.H. Jan Danser, MD, Frans Boomsma, Erik Frandsen, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(10):1873–1879
https://doi.org/10.2337/dc09-0168
Published: 08 July 2009
View article titled, Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
Open the PDF for Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria in another window
Includes: Supplementary data
Journal Articles

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study

Davina Burt, PHD, Graziella Bruno, MD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Silvia Pinach, MSC, Paolo Cavallo Perin, MD, Gabriella Gruden, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1269–1271
https://doi.org/10.2337/dc08-2271
Published: 14 April 2009
View article titled, Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
Open the PDF for Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study in another window
Journal Articles

Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Miranda T. Schram, MSC, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Francesco Giorgino, MD, PHD, Pertti Ebeling, PHD, John H. Fuller, FRCP, Coen D. Stehouwer, MD, PHD, the EURODIAB Prospective Complications Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(7):2165–2173
https://doi.org/10.2337/diacare.26.7.2165
Published: 01 July 2003
View article titled, Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle>
Open the PDF for Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: <subtitle>The EURODIAB Prospective Complications Study</subtitle> in another window
Journal Articles

C-Reactive Protein in Type 1 Diabetes and Its Relationship to Coronary Artery Calcification

Helen M. Colhoun, MD, Casper Schalkwijk, PhD, Michael B. Rubens, FRCR, Coen D.A. Stehouwer, MD
Journal: Diabetes Care
Diabetes Care 2002;25(10):1813–1817
https://doi.org/10.2337/diacare.25.10.1813
Published: 01 October 2002
View article titled, C-Reactive Protein in Type 1 Diabetes and Its Relationship to Coronary Artery Calcification
Open the PDF for C-Reactive Protein in Type 1 Diabetes and Its Relationship to Coronary Artery Calcification in another window